- Home
- VRDN vs NABL Comparison
VRDN vs NABL Comparison
Compare VRDN & NABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- NABL
- Stock Information
- Founded
- VRDN 2006
- NABL 2000
- Country
- VRDN United States
- NABL United States
- Employees
- VRDN N/A
- NABL N/A
- Industry
- VRDN Medical Specialities
- NABL Computer Software: Prepackaged Software
- Sector
- VRDN Health Care
- NABL Technology
- Exchange
- VRDN Nasdaq
- NABL Nasdaq
- Market Cap
- VRDN 1.6B
- NABL 1.9B
- IPO Year
- VRDN N/A
- NABL N/A
- Fundamental
- Price
- VRDN $13.48
- NABL $7.09
- Analyst Decision
- VRDN Buy
- NABL Buy
- Analyst Count
- VRDN 12
- NABL 4
- Target Price
- VRDN $36.44
- NABL $9.38
- AVG Volume (30 Days)
- VRDN 766.3K
- NABL 1.2M
- Earning Date
- VRDN 05-07-2025
- NABL 03-03-2025
- Dividend Yield
- VRDN N/A
- NABL N/A
- EPS Growth
- VRDN N/A
- NABL 24.64
- EPS
- VRDN N/A
- NABL 0.16
- Revenue
- VRDN $302,000.00
- NABL $466,147,000.00
- Revenue This Year
- VRDN N/A
- NABL $8.45
- Revenue Next Year
- VRDN $17,629.40
- NABL $9.68
- P/E Ratio
- VRDN N/A
- NABL $44.34
- Revenue Growth
- VRDN N/A
- NABL 10.49
- 52 Week Low
- VRDN $11.40
- NABL $6.75
- 52 Week High
- VRDN $27.20
- NABL $15.49
- Technical
- Relative Strength Index (RSI)
- VRDN 32.50
- NABL 32.90
- Support Level
- VRDN $14.03
- NABL $7.09
- Resistance Level
- VRDN $15.91
- NABL $7.38
- Average True Range (ATR)
- VRDN 0.67
- NABL 0.27
- MACD
- VRDN -0.10
- NABL 0.03
- Stochastic Oscillator
- VRDN 6.51
- NABL 10.25
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.
About NABL N-able Inc.
N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. it also has a presence in the United Kingdom and all other International regions.